 United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
| Descriptor ID |
D014486
|
| MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 | | 2000 | 0 | 4 | 4 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 2 | 2 | | 2003 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 1 | 2 | 3 | | 2007 | 1 | 4 | 5 | | 2008 | 1 | 3 | 4 | | 2009 | 2 | 5 | 7 | | 2010 | 0 | 4 | 4 | | 2011 | 1 | 2 | 3 | | 2012 | 2 | 14 | 16 | | 2013 | 1 | 3 | 4 | | 2014 | 1 | 5 | 6 | | 2015 | 2 | 14 | 16 | | 2016 | 1 | 9 | 10 | | 2017 | 2 | 8 | 10 | | 2018 | 1 | 4 | 5 | | 2019 | 2 | 9 | 11 | | 2020 | 1 | 7 | 8 | | 2021 | 0 | 9 | 9 | | 2022 | 0 | 9 | 9 | | 2023 | 0 | 3 | 3 | | 2024 | 2 | 7 | 9 | | 2025 | 0 | 6 | 6 | | 2026 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Anderson B, Pascal C, Butler MGK, Chin AR, Long AJ, Sindher SB, Anagnostou A, Arasi S, Bégin P, Ciaccio CE, Eiwegger T, Fiocchi A, Fleischer DM, Garcia-Llorett M, Kim EH, Leonard S, Maskatia ZR, Perrett KP, Shreffler W, Upton J, Chinthrajah RS. Biologics and Novel Therapeutics in Food Allergy. J Allergy Clin Immunol Pract. 2026 Apr; 14(4):762-770.
-
Shinde MU, Shapiro K, Hou L, Coughlin K, Madow AM, Shebl FM, Bright P, Pocobelli G, Ralston JD, Graham VF, Nolan MB, Binswanger IA, Pratt N, Hua W, Cocoros NM, Perez-Vilar S. Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness Studies. Pharmacoepidemiol Drug Saf. 2026 Apr; 35(4):e70363.
-
Conway K, Knoetze M, Swanepoel W, Sharma A, Nassiri A, Manchaiah V. Marketing Practices and Information Quality for Over-the-counter (OTC) Hearing Aids on Amazon.com. Otol Neurotol. 2026 Feb 01; 47(2):e145-e150.
-
Almasri H, Karna R, Sidhu G, Khataniar H, Bassett J, Bilal M. Analysis of Reported Adverse Events Associated with Sphincterotomes: An FDA Manufacturer and User Facility Device Experience (MAUDE) Database Study. Dig Dis Sci. 2025 Oct; 70(10):3552-3562.
-
Pearson AD, Chi S, Laetscht TW, Marshall L, Raetz E, George RE, Chesler L, Karres D, Scobie N, Knoderer H, Weigel B, Teachey D, Sonke GS, Seibel N, Pappo A, Nysom K, Muscal J, Molenaar J, McDonough J, Macy ME, Ludwinski D, Lin C, Ligas F, Lesa G, Knox L, Kirschbaum M, Kieran M, Kholmanskikh O, Jacobson A, Heenen D, Hawkins DS, Glade Bender J, Fox E, Demolis P, de Rojas T, Cox MC, Chauvin B, Blanc P, Vassal G. Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration. Eur J Cancer. 2025 Aug 26; 226:115629.
-
Shendre A, Liu X, Chiang C, Goodwin A, Oteng SR, Deypalubos JAF, Zhang S, Wang L, Liu J, Abbasi MY, Aruldhas BW, Zaidi SS, Kirkpatrick LM, Silva LD, Overholser BR, O'Kane AM, Kannankeril PJ, Patrick SW, Wiese AD, Quinney SK, Li L. Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations. Pharmacotherapy. 2025 06; 45(6):367-385.
-
Elder C, Pellinen J, Terman SW. The Epilepsy Drug Pipeline: Update on Near-to-Market Therapies. Semin Neurol. 2025 Apr; 45(2):287-297.
-
Pearson AD, Mueller S, Filbin MG, Grill J, Hawkins C, Jones C, Donoghue M, Drezner N, Weiner S, Russo M, Dun MD, Allen JE, Alonso M, Benaim E, Buenger V, de Rojas T, Desserich K, Fox E, Friend J, Glade Bender J, Hargrave D, Jensen M, Kholmanskikh O, Kieran MW, Knoderer H, Koschmann C, Lesa G, Ligas F, Lipsman N, Ludwinski D, Marshall L, McDonough J, McNicholl AG, Mirsky D, Monje M, Nysom K, Pappo A, Rosenfield A, Scobie N, Slaughter J, Smith M, Souweidane M, Straathof K, Ward L, Weigel B, Zamoryakhin D, Karres D, Vassal G. Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2025 Feb 25; 217:115230.
-
Dantzer JA, Shaker MS, Greenhawt M. Evolving Food Allergy Clinical Trials to Become More Patient-Centered. J Allergy Clin Immunol Pract. 2025 Apr; 13(4):763-772.
-
Kao DP, Martin JL, Aquilante CL, Shalowitz EL, Leyba K, Kudron E, Reusch JEB, Regensteiner JG. Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration. BMJ Open Diabetes Res Care. 2024 Dec 05; 12(6).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|